Suppr超能文献

新型二十二碳六烯酸(DHA)含量丰富的饲料成分未提取的雨生红球藻生物质的毒理学评价。

Toxicological evaluation of an unextracted Aurantiochytrium limacinum biomass, a novel docosahexaenoic acid rich feed ingredient.

机构信息

Alltech Ireland, Sarney, Summerhill Road, Dunboyne, Co Meath, Ireland.

Alltech Ireland, Sarney, Summerhill Road, Dunboyne, Co Meath, Ireland.

出版信息

Food Chem Toxicol. 2020 Jul;141:111397. doi: 10.1016/j.fct.2020.111397. Epub 2020 May 13.

Abstract

The purpose of this paper was to evaluate the toxicological potential of a heterotrophically grown unextracted Aurantiochytrium limacinum biomass (AURA) when used as a food additive. The following toxicological assessments were conducted on this novel docosahexaenoic acid rich feed ingredient: Mutagenic activity was tested by means of the Ames' test using five Salmonella typhimurium strains; clastogenic activity was investigated using the micronucleus test in male and female Sprague Dawley rats; genotoxic activity was assessed by means of the in vitro metaphase analysis tests in human lymphocytes; oral toxicity was tested by administration of AURA at various concentrations; eye and skin irritation was assessed in rabbits according to OECD guidelines; skin sensitivity was established in guinea pigs by means of the Buehler test. All conducted tests were considered valid under the experimental conditions. No significant mutagenic activity or clastogenic activity was observed. Genotoxic activity in human lymphocytes was not induced. Oral administration of 276 mg AURA/kg bw and 2000 mg AURA/kg bw resulted in no mortality or signs of acute toxicity. Daily administration of 1000 mg AURA/kg bw caused no mortality or biologically relevant signs of toxicity and was established as the No Observable Adverse Effect Level. AURA was also found to be a non-irritant for the eye and skin of the rabbit and was non-sensitizing to guinea pig skin.

摘要

本文旨在评估作为食品添加剂使用的异养生长未经提取的雨生红球藻(AURA)的毒理学潜力。对这种新型富含二十二碳六烯酸的饲料成分进行了以下毒理学评估:通过使用 5 株鼠伤寒沙门氏菌进行 Ames 试验测试了致突变活性;通过雄性和雌性 Sprague Dawley 大鼠的微核试验研究了断裂活性;通过体外中期分析试验在人淋巴细胞中评估了遗传毒性活性;通过不同浓度的 AURA 给药测试了口服毒性;根据 OECD 指南在兔子中评估了眼睛和皮肤刺激性;通过 Buehler 试验在豚鼠中建立了皮肤敏感性。所有进行的测试在实验条件下均被认为是有效的。未观察到明显的致突变活性或断裂活性。未诱导人淋巴细胞的遗传毒性活性。以 276mg AURA/kg bw 和 2000mg AURA/kg bw 的剂量口服给予 AURA 不会导致死亡或出现急性毒性的迹象。每天给予 1000mg AURA/kg bw 不会导致死亡或产生有生物学意义的毒性迹象,并确定为无观察到不良效应水平。还发现 AURA 对兔子的眼睛和皮肤无刺激性,对豚鼠皮肤无致敏性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验